{"entity":{"id":"nct06801665","kind":"trial","name":"FMT+ QL1706+Bevacizumab+ XELOX as First-line Treatment for Advanced MSS-type Colorectal Cancer With Liver Metastasis","aka":[],"tldr":"A phase 2 trial in colorectal cancer, run by Hua Jiang, now recruiting.","summary":"FMT+ QL1706+Bevacizumab+ XELOX as First-line Treatment for Advanced MSS-type Colorectal Cancer With Liver Metastasis is a phase 2, interventional study registered as NCT06801665 by Hua Jiang, with a registry enrolment figure of 30 participants, started 2025-04-17 and due to reach its primary completion in 2027-02-01. Interventions recorded: FMT+QL1706+Bevacizumab+XELOX. Conditions listed: Colorectal Cancer Liver Metastasis. Primary outcome: Objective Response Rate (ORR). Colorectal eligibility wording from the registry: \"Histological or cytological confirmed advanced colorectal cancer with liver metastasis\". Sites: China. No results are recorded here; the registry entry is the source.","status":"recruiting","asOf":"2026-09-24","links":[{"label":"ClinicalTrials.gov NCT06801665","url":"https://clinicaltrials.gov/study/NCT06801665"}],"tags":["ctgov-ingest","colorectal-deep-dive"],"related":[],"cancers":["rectal-cancer","colon-cancer"],"sections":[],"technologies":[],"targets":[],"drugs":[],"companies":[],"institutions":[],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":[],"nct":"NCT06801665","phase":"2","setting":"Fecal Microbiota Transplantation Combined With QL1706, Bevacizumab, and XELOX as First-line Treatment for Advanced MSS-type Colorectal Cancer With Liver Metastasis: A Prospective, Multi-center, Single-arm Phase II Study","sponsor":"Hua Jiang","participation":[{"nct":"NCT06801665","source":"https://clinicaltrials.gov/study/NCT06801665","fetchedAt":"2026-10-07T16:55:06.589Z","studySha256":"f106c31c0b37a02d755b018c5b5c03d24d9efae5c45a066969428d9efce92aac","overallStatus":"RECRUITING","lastUpdatePosted":"2026-09-24","leadSponsor":"Hua Jiang","collaboratorCount":0,"minimumAge":"18 Years","maximumAge":"75 Years","sex":"ALL","healthyVolunteers":false,"hasEligibility":true,"enrolment":30,"enrolmentType":"ESTIMATED","siteCount":1,"recruitingSiteCount":1,"countries":["China"]}],"started":"2025-04-17","startedType":"actual","enrolled":30,"enrolledBasis":"registry","outcomes":[]},"route":"/trials/nct06801665/","neighbours":{"cancer":[{"id":"colon-cancer","kind":"cancer","name":"Colon cancer (adenocarcinoma of the colon)","route":"/cancers/colon-cancer/"},{"id":"rectal-cancer","kind":"cancer","name":"Rectal cancer","route":"/cancers/rectal-cancer/"}],"term":[{"id":"colorectal-trials-open-today","kind":"term","name":"Colorectal cancer trials open today (registry snapshot)","route":"/terms/colorectal-trials-open-today/"}]}}